ARTICLES
Defining new standards for adjuvant therapy of testis cancer
CR Nichols, R Gonin, and R Foster
JCO Nov 1 1995: 2681–2683. [PDF]
Human immunodeficiency virus-associated neoplasia: changing spectrum?
LD Kaplan
JCO Nov 1 1995: 2684–2687. [PDF]
	Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study
	L Gianni, E Munzone, G Capri, F Fulfaro, E Tarenzi, F Villani, C Spreafico, A Laffranchi, A Caraceni, and C Martini
	JCO Nov 1 1995: 2688–2699. [Abstract] [PDF]
	Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors
	RJ Motzer, J Sheinfeld, M Mazumdar, DF Bajorin, GJ Bosl, H Herr, P Lyn, and V Vlamis
	JCO Nov 1 1995: 2700–2704. [Abstract] [PDF]
	Testicular germ cell tumors and human immunodeficiency virus infection: a report of 26 cases. Italian Cooperative Group on AIDS and Tumors
	D Bernardi, R Salvioni, E Vaccher, L Repetto, N Piersantelli, B Marini, R Talamini, and U Tirelli
	JCO Nov 1 1995: 2705–2711. [Abstract] [PDF]
	Randomized cooperative study of perioperative chemotherapy in breast cancer
	MR Sertoli, P Bruzzi, P Pronzato, P Queirolo, D Amoroso, L Del Mastro, M Venturini, A Vigani, G Bertelli, and E Campora
	JCO Nov 1 1995: 2712–2721. [Abstract] [PDF]
	Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer
	BL Weber, C Vogel, S Jones, H Harvey, L Hutchins, J Bigley, and J Hohneker
	JCO Nov 1 1995: 2722–2730. [Abstract] [PDF]
	Advanced breast cancer: a phase II trial with gemcitabine
	J Carmichael, K Possinger, P Phillip, M Beykirch, H Kerr, J Walling, and AL Harris
	JCO Nov 1 1995: 2731–2736. [Abstract] [PDF]
	Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy
	RJ Couzi, KJ Helzlsouer, and JH Fetting
	JCO Nov 1 1995: 2737–2744. [Abstract] [PDF]
	p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings
	T Jansson, M Inganas, S Sjogren, T Norberg, A Lindgren, L Holmberg, and J Bergh
	JCO Nov 1 1995: 2745–2751. [Abstract] [PDF]
	Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study
	DR Barnhill, RJ Kurman, MF Brady, GA Omura, E Yordan, FT Given, PR Kucera, and LD Roman
	JCO Nov 1 1995: 2752–2756. [Abstract] [PDF]
	Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer
	M Lise, D Nitti, A Marchet, T Sahmoud, M Buyse, N Duez, M Fiorentino, JG Dos Santos, R Labianca, and P Rougier
	JCO Nov 1 1995: 2757–2763. [Abstract] [PDF]
	Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas
	M Mohiuddin, WF Regine, J Stevens, F Rosato, D Barbot, W Biermann, and R Cantor
	JCO Nov 1 1995: 2764–2768. [Abstract] [PDF]
	Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination
	M Krismann, B Todt, J Schroder, D Gareis, KM Muller, S Seeber, and J Schutte
	JCO Nov 1 1995: 2769–2775. [Abstract] [PDF]
	Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma
	ET Creagan, RJ Dalton, DL Ahmann, SH Jung, RF Morton, RM Langdon, Jr, J Kugler, and LJ Rodrigue
	JCO Nov 1 1995: 2776–2783. [Abstract] [PDF]
	Gallium scans in the evaluation of residual masses after chemotherapy for seminoma
	GP Warren and LH Einhorn
	JCO Nov 1 1995: 2784–2788. [Abstract] [PDF]
	Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation
	GB McCowage, MR Vowels, PJ Shaw, L Lockwood, and H Mameghan
	JCO Nov 1 1995: 2789–2795. [Abstract] [PDF]
	Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults
	BH Kushner, PA Meyers, WL Gerald, JH Healey, MP La Quaglia, P Boland, N Wollner, ES Casper, A Aledo, and G Heller
	JCO Nov 1 1995: 2796–2804. [Abstract] [PDF]
	Pulmonary thromboembolism in childhood leukemia: 8-years' experience in a pediatric hematology center
	C Uderzo, P Faccini, A Rovelli, M Arosio, PF Marchi, A Riva, G Marraro, A Balduzzi, and G Masera
	JCO Nov 1 1995: 2805–2812. [Abstract] [PDF]
	Pediatric desmoid tumor: retrospective analysis of 63 cases
	LB Faulkner, SI Hajdu, U Kher, M La Quaglia, PR Exelby, G Heller, and N Wollner
	JCO Nov 1 1995: 2813–2818. [Abstract] [PDF]
	Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group
	I Teodorovic, S Pittaluga, JC Kluin-Nelemans, JH Meerwaldt, A Hagenbeek, M van Glabbeke, R Somers, L Bijnens, EM Noordijk, and CD Peeters
	JCO Nov 1 1995: 2819–2826. [Abstract] [PDF]
	Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia
	P Anderlini, RS Benjamin, FC Wong, HM Kantarjian, M Andreeff, SM Kornblau, S O'Brien, B Mackay, MS Ewer, and SA Pierce
	JCO Nov 1 1995: 2827–2834. [Abstract] [PDF]
	Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors
	S Kaul, LN Igwemezie, DJ Stewart, SZ Fields, M Kosty, N Levithan, R Bukowski, D Gandara, G Goss, and P O'Dwyer
	JCO Nov 1 1995: 2835–2841. [Abstract] [PDF]
	Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation
	DA Rinaldi, HA Burris, FA Dorr, JR Woodworth, JG Kuhn, JR Eckardt, G Rodriguez, SW Corso, SM Fields, and C Langley
	JCO Nov 1 1995: 2842–2850. [Abstract] [PDF]
	Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study
	G Bertelli, A Gozza, GB Forno, MG Vidili, S Silvestro, M Venturini, L Del Mastro, O Garrone, R Rosso, and D Dini
	JCO Nov 1 1995: 2851–2855. [Abstract] [PDF]
	Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial
	RM Goldberg, CL Loprinzi, JA Mailliard, JR O'Fallon, JE Krook, C Ghosh, RD Hestorff, SF Chong, NF Reuter, and TG Shanahan
	JCO Nov 1 1995: 2856–2859. [Abstract] [PDF]
Avoiding treatment errors: a suggestion
J Richard
JCO Nov 1 1995: 2860. [PDF]

SPECIAL DEPARTMENTS
Erratum
	Chemoradiotherapy With or Without Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Limited-Stage Small-Cell Lung Cancer: A Prospective Phase III Randomized Study of the Southwest Oncology Group
	Paul A. Bunn, Jr, John Crowley, Karen Kelly, Mark B. Hazuka, Kristie Beasley, Christine Upchurch, and Robert Livingston
	JCO Nov 1 1995: 2860-a. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.